| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER | /s/ Benjamin Hohl | 17 Feb 2026 | 0001882764 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ELVN | Common Stock | Award | $0 | +25,000 | +69% | $0.000000 | 61,000 | 12 Feb 2026 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ELVN | Stock Option (right to buy) | Award | $0 | +150,000 | $0.000000 | 150,000 | 12 Feb 2026 | Common Stock | 150,000 | $27.16 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| F2 | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
| F3 | 1/4th of the shares subject to the option will vest on February 12, 2027 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |